CCI
CRSP icon

Columbus Circle Investors’s CRISPR Therapeutics CRSP Stock Holding History

Columbus Circle Investors’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$8.58M Sell
56,058
-59,468
-51% -$7.03M 0.38% 95
2020
Q3 		$9.66M Sell
115,526
-91,579
-44% -$8.12M 0.42% 88
2020
Q2 		$15.2M Buy
207,105
+68,194
+49% +$3.99M 0.61% 65
2020
Q1 		$5.89M Buy
138,911
+40,023
+40% +$2.07M 0.32% 106
2019
Q4 		$6.02M Buy
+98,888
New +$5.4M 0.26% 117
2018
Q3 		– Sell
-47,628
Closed -$2.8M – 181
2018
Q2 		$2.8M Buy
+47,628
New +$2.71M 0.06% 178

Other funds holding CRSP

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return